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Abstract
APJ, a member of the human G protein-coupled seven-transmembrane receptor family, has been shown to serve as a coreceptor for the
entry of human immunodeficiency virus type I (HIV-1) and simian immunodeficiency virus (SIV), and it is dramatically expressed in central
nervous system (CNS)-based cells. In this study, expression of APJ tagged with the green fluorescent protein (GFP) and a fluorescent
peptide, 5-carboxyfluorescein (5-CF) conjugated Apelin-13, were utilized for studying receptor internalization and recycling, in stably
expressing indicator cells, human neurons, primary CNS microvascular endothelial cells (MVECs), and astrocytes. Fusion of the C-terminus
of APJ to the N-terminus of GFP did not alter receptor ligand binding and functions, including signaling and internalization. Using 293 cells
stably expressing APJ-GFP, we demonstrated that rapid internalization of the APJ receptor was induced by stimulation with Apelin-36 and
Apelin-13, in a dose-dependent manner. Furthermore, investigations showed that the internalized APJ was colocalized with transferrin
receptors, suggesting that the internalization of APJ induced by Apelin is likely to be via clathrin-coated pits. Interestingly, we found that
the internalized APJ molecules were recycled to the cell surface within 60 min after removal of Apelin-13, but most of the internalized APJ
still remained in the cytoplasm, even 2 h after washout of Apelin-36. The intact cytoplasmic C-terminal domain was found to be required
for ligand-induced APJ internalization. Human neurons were dramatically stained by the APJ-binding fluorescent peptides. Primary human
fetal astrocytes were less strongly labeled with 5-CF-Apelin-13, and in primary human CNS MVECs only weak distribution of green
fluorescence specific for APJ in the cytoplasm was observed. Apelin-36 blocked cell membrane fusion mostly due to steric interference, with
only a very modest effect on receptor internalization. The CNS represents a unique reservoir site for HIV-1. As such, molecular therapeutics
and small molecular inhibitors of HIV-1 entry via this unique CNS receptor are now able to be rationally designed.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
APJ, also known as angiotensin receptor-like
(AGTRL1), is a member of the G protein-coupled, seven-
transmembrane receptor family and was first identified from
human genomic DNA by O’Dowd et al. (1993). Studies
with Northern blot analysis and in situ hybridization indi-
cated that APJ mRNA was detected in the central nervous
system (CNS), including regions of the hippocampus, stri-
atum, thalamus, cortex, and cerebellum (Edinger et al.,
1998; Matsumoto et al., 1996; O’Dowd et al., 1993). Recent
research utilizing immunocytochemical staining with a
polyclonal anti-APJ antibody and reverse transcriptase-
polymerase chain reaction (RT-PCR) showed that APJ was
expressed at a high level in neurons and oligodendrocytes
and at lower levels in astrocytes, suggesting that the APJ
receptor may play certain important physiological roles in
the CNS (Choe et al., 2000).
The endogenous peptidic ligand for APJ receptor, Ape-
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lin, was first isolated from bovine stomach extracts (Tate-
moto et al., 1998). Subsequently, the protein sequences of
human, rat, and mouse Apelin pre-pro-proteins were de-
duced from the cDNAs (Habata et al., 1999; Hosoya et al.,
2000; Lee et al., 2000; Tatemoto et al., 1998). The mature
Apelin peptide consisting of 36 amino acid residues (Ape-
lin-36) and the shorter C-terminal peptide with 13 amino
acid residues (Apelin-13) were demonstrated to induce sig-
naling responses in APJ-transfected cells and neural cells
(Choe et al., 2000; Hosoya et al., 2000). In a rat model,
Apelins were found to play an important role in the hypo-
thalamic regulation of water intake (Lee et al., 2000; Reaux
et al., 2001; Taheri et al., 2002;), and to lower blood pres-
sure via a nitric oxide-dependent mechanism (Lee et al.,
2000; Tatemoto et al., 2001).
It is well-known that entry of human immunodeficiency
virus type I (HIV-1) into target cells requires binding of the
virus envelope glycoprotein (gp120) to CD4, followed by
interactions with a seven-transmembrane receptor as a viral
coreceptor. All primary HIV-1 strains use the chemokine
receptor CCR5 (M-tropic), CXCR4 (T-tropic), or both (du-
al-tropic) as major coreceptors (Choe et al., 1996; Deng et
al., 1996; Doranz et al., 1996; Dragic et al., 1996; Feng et
al., 1996). Recent studies have shown that the APJ receptor
is employed by T-tropic, M-tropic, dual-tropic HIV-1 and
simian immunodeficiency viruses (SIV) for supporting env-
mediated membrane fusion or viral entry in vitro (Choe et
al., 1998; Edinger et al., 1998; Puffer et al., 2000; Singh et
al., 1999; Zhang et al., 1998). It was reported that some
brain-derived viruses also use APJ as a coreceptor (Albright
et al., 1999; Shieh et al., 1998). With the detection of
expression of APJ in the CNS, these observations suggested
that the APJ receptor might play an important role in HIV-1
infection and pathogenesis in the CNS. Apelin, the natural
ligand of APJ, has been found to be able to block the
activity of APJ as an HIV-1 coreceptor (Cayabyab et al.,
2000; Puffer et al., 2000; Zou et al., 2000). G-protein-
coupled receptors (GPCR), such as CCKAR (Tarasova et
al., 1997), CXCR4 (Amara et al., 1997; Orsini et al., 1999;
Tarasova et al., 1998), CCR5 (Mack et al., 1998), and CCR3
(Zimmerman et al., 1999), can be induced to undergo rapid
internalization upon binding of agonists. In general, such
ligand-induced receptor internalization regulates the num-
ber of functionally active GPCRs on the plasma membrane.
Previous studies have shown that entry of HIV-1 into target
cells is independent of the ability of the coreceptor to
internalize (Aramor et al., 1997; Doranz et al., 1996; Hev-
eker et al., 1998). The internalization of coreceptors con-
tributes to chemokine inhibition of virus entry (Amara et al.,
1997; Mack et al., 1998; Signoret et al., 1997), but transient
down-regulation of the coreceptor(s) may not be the most
efficient way of blocking HIV-1 infection in vivo (Stauber
et al., 1999). Certain viral envelope gp120s were reported to
bind to CXCR4 and to induce rapid internalization of cell-
surface CXCR4, both in the presence and in the absence of
CD4 (Tarasova et al., 1997).
Although APJ is identified as a coreceptor for HIV-1
fusion and infection, little is known about the internalization
and recycling of this receptor. In the present study, we used
an APJ-GFP fusion protein and a 5-carboxyfluorescein (5-
CF)-conjugated Apelin-13 to characterize the internaliza-
tion and recycling of APJ receptor upon stimulation with
natural ligands, a phorbol ester (phorbol myristate acetate:
PMA), and HIV-1 gp120s in transfected cells and primary
human cells. We also investigated the role internalization of
the APJ coreceptor plays in HIV-1 infection and in ligand
inhibition of virus fusion and infection.
Results
Expression and function of APJ-EGFP and APJ329-
EGFP
To investigate the internalization of the APJ receptor, we
constructed two expression vectors, pAPJ-EGFP and
pAPJ329-EGFP, consisting of the human APJ receptor and
a C-terminally truncated APJ, respectively, both fused to the
enhanced version of the green fluorescent protein (EGFP) at
the C-terminus. The stably expressing 293 cell lines were
established for characterizing the function of APJ-EGFP
and APJ329-EGFP. To determine the effects of APJ-EGFP
and APJ329-EGFP on signal transduction in response to
Apelin-36, we measured intracellular Ca2 mobilization in
stably transfected 293 cells upon stimulation with 3 M
Apelin-36. It was demonstrated that APJ-EGFP maintained
signaling activity comparable to wild-type APJ, whereas a
lower intensity Ca2 response was observed for APJ329-
EGFP (Fig. 1a). The gene reporter fusion assay was also
utilized to evaluate the HIV-1 coreceptor activity of both
APJ-EGFP and APJ329-EGFP. Compared to APJ, both
fusion proteins exhibited similarly high levels of luciferase
activity (Fig. 1b), suggesting that the EGFP fusion protein
did not alter the HIV-1 coreceptor activity of APJ.
Ligand-induced internalization of APJ-EGFP
The EGFP fusion protein at the C-terminus made it possible
to assess the ligand-induced internalization of the APJ receptor
in stably expressing 293 cells by fluorescence microscopy. In
the absence of peptide ligands, APJ-EGFP primarily localized
to the cell surface (Fig. 2a). After exposure to 2 M Apelin-13
or Apelin-36 at 37°C for 30 min, the receptor was dramatically
redistributed in the cytoplasm with distinct perinuclear accu-
mulation. The localization of APJ-EGFP was not altered by
200 nM SDF-1 (Fig. 2a), which in the same concentration
could induce significant internalization of the human chemo-
kine receptor, CXCR4 (Fig. 2b).
To further characterize internalization of APJ, cell-sur-
face expression of APJ in stably expressing 293 cells upon
exposure to Apelins was analyzed by flow cytometry, with
the anti-APJ monoclonal antibody, MB856. The internal-
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ization of APJ was induced rapidly upon treatment with
Apelin-13 and Apelin-36. This effect was already detectable
5 min after Apelin stimulation and reached a maximum after
30 min (Fig. 2c). APJ internalization was induced by Ape-
lins in a dose-dependent manner, and approximately 50% of
cell-surface APJ was internalized by Apelins at 2 M (Fig.
2d). Apelin-13 and Apelin-36 showed no difference in dose-
dependence and kinetics in inducing APJ internalization.
Colocalization of internalized APJ-EGFP with transferrin
To investigate the intracellular route of internalized APJ,
the APJ-EGFP stably expressing 293 cells and CHO cells
were treated with human transferrin coupled to tetramethyl-
rhodamine, which marks early endosomes, or LysoTracker
Red, which is taken up into lysosomes. In both 293 and
CHO cells, upon stimulation with Apelin-13 and Apelin-36,
the internalized APJ-EGFP was primarily colocalized with
transferrin and appeared as yellow spots (Fig. 3). In con-
trast, the cells treated with LysoTracker Red revealed no
overlap of green and red colors. Taken together, these re-
sults indicate that the internalized APJ-EGFP by Apelins is
associated with early endosomes.
Recycling of internalized APJ to the cell surface
The recovery of internalized APJ receptor to the cell
surface was investigated using the APJ-EGFP stably ex-
pressing 293 cells. After stimulation with 2 M Apelin-13
or Apelin-36 at 37°C for 30 min, cells were washed thor-
oughly with medium and incubated for the time periods
indicated. To inhibit the de novo protein synthesis, cells
were always incubated in the presence of cycloheximide.
The results are shown in Fig. 4. After removal of Apelin-13,
the internalized APJ-EGFP was partly recycled to the cy-
toplasmic membrane within 30 min of incubation. Further
Fig. 1. Expression and function of APJ-EGFP and APJ329-EGFP. (a) Intracellular Ca2 mobilization. Intracellular Ca2 concentrations in nontransduced 293
cells, or 293 cells stably expressing wild-type or mutant APJ, were measured in response to Apelin-36 (3 M). The data shown are representative of at least
three independent experiments. (b) Coreceptor activity of APJ. Target cells were cotransfected with plasmids encoding coreceptors, CD4, and luciferase under
the control of the T7 promoter. 293 effector cells were infected with a vaccinia virus encoding T7 polymerase and a vaccinia virus encoding the HIV-1
envelope protein (strain, 89.6). Cell mixtures were maintained at 37°C for 4 to 6 h. Cell fusion was determined by a luciferase assay. Values are expressed
as luciferase activity (RLU/s). All experiments were repeated at least three times, and results are expressed as the mean value  SE.
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Fig. 2. Internalization of APJ-EGFP upon stimulation with Apelins. (a) 293 cells stably expressing APJ-EGFP treated with only medium, Apelin-36,
Apelin-13, and SDF-1 as a control at 37°C for 40 min. (b) 293 cells stably expressing CXCR4-EGFP treated with medium only, SDF-1, Apelin-36, or
Apelin-13 at 37°C for 40 min. (c) Dependence of APJ internalization on concentrations of Apelins. The stably transfected 293 cells were treated with
increasing concentrations of peptide for 30 min at 37°C and, after washing, surface APJ was determine by FACS, as described above. (d) Time course of
APJ internalization induced by Apelins. Cells were incubated with 2 M Apelins at 37°C for the indicated times, and after washing, were analyzed for APJ
expression as described above. All experiments were repeated at least three times, and results are expressed as the mean value  SE.
incubation resulted in full recovery of internalized APJ-
EGFP to the cell surface, whereas after washout of Apelin-
36, the internalized APJ-EGFP was still maintained in the
cytoplasm, even after 120 min of incubation.
Role of the C-terminus of APJ in ligand-induced
internalization
We constructed a C-terminally truncated APJ, fused to
EGFP at its C-terminus, and transfected the moiety into 293
cells, for establishing a stable expressing cell line. The
cell-surface expression, and activity as a coreceptor for
HIV-1, of APJ329-EGFP was comparable to APJ-EGFP,
but intracellular calcium mobilization in response to Ape-
lin-36 was much weaker than with APJ-EGFP. To investi-
gate the role that the APJ C-terminus plays in ligand-
induced internalization, the stably expressing cells were
plated onto two chamber slides overnight, and treated with
ligands at 37°C for 30 min. Unlike in Fig. 2 which demon-
strates that exposure to Apelin-36 caused a dramatic inter-
nalization of APJ-EGFP, Apelin-36 did not affect cell-
surface localization of APJ329-EGFP (Fig. 5). Of note,
C-terminus truncation of CXCR4 also ablates internaliza-
tion with SDF-1 (data not illustrated).
Internalization of 5-CF-Apelin-13 in human astrocytes,
brain MVECs, and mature neurons
As reported previously (Choe et al., 2000); the APJ
receptor is expressed at high levels in neurons and oligo-
dendrocytes and at lower levels in astrocytes, but these
primary cells are difficult to transfect with APJ-EGFP.
Thus, a fluorescent peptide ligand, 5-CF-conjugated Apelin-
13, was developed to further study the internalization of the
APJ receptor in primary human cells and cultured neurons.
First, we examined the binding and internalization of this
fluorescent peptide in APJ stably transfected 293 cells. As
shown in Fig. 6, the cell surface was stained with the
fluorescent peptide after treatment with 5 M 5-CF-Ape-
lin-13 at 4°C for 30 min. Of note, the green fluorescence
was distributed in the cytoplasm upon incubation with
5-CF-Apelin-13 at 37°C for 30 min. The same treatment of
C-terminally truncated APJ stably expressing 293 cells,
with 5-CF-Apelin-13, resulted in no distribution of fluores-
cent peptides in the cytoplasm. Cells lacking APJ, as neg-
ative controls, routinely lacked fluorescence in these studies
(not illustrated). These results indicated that 5-CF-Ape-
lin-13 binds to APJ and internalizes into the cytoplasm,
together with the receptor.
Fig. 3. Colocalization of internalized APJ with transferrin. The stable APJ-EGFP expressing 293 and CHO cells (in green) were stained with tetramethyl-
rhodamine-transferrin (in red) or LysoTracker Red (in red). Colocalization of APJ-EGFP with transferrin or LysoTracker appears as yellow. The data shown
are representative of at least three independent experiments.
26 N. Zhou et al. / Virology 307 (2003) 22–36
The primary CNS cells, human MVECs, astrocytes, and
cultured mature human neurons, differentiated from the
NT2 cell-line, were also used for studying internalization of
this fluorescent peptide. After incubation with 5 M fluo-
rescent Apelin-13 at 37°C for 40 min, astrocytes were
clearly but relatively weakly labeled with green 5-CF-Ape-
lin-13 in the cytoplasm, while a dense green fluorescence in
the entire cell was observed in differentiated NT2 cells,
which grow in culture in densely packed multicellular
“balls” (Mukhtar and Pomerantz, 2000). In human brain
MVECs, little distribution of fluorescent peptide in the
cytoplasm was observed (Fig. 6).
Effects of PMA and the HIV-1 envelope glycoprotein
gp120 on APJ internalization
It has been shown that CXCR4 and CD4, but not CCR5,
are internalized from the cell surface in response to phorbol
ester stimulation (Orsini et al., 1999; Signoret et al., 1997,
1998). We examined the effect of PMA on internalization of
Fig. 4. Recovery of internalized APJ to the cell surface. The stable APJ-EGFP expressing cells were first incubated for 30 min at 37°C with 2 M Apelin-13
or Apelin-36. After internalization, ligands were removed by washing with medium, and the cells were further cultured in medium in the presence of 100
g/ml cycloheximide at 37°C for various periods of the indicated times and then examined for APJ expression. The data shown are representative of at least
three independent experiments.
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the APJ receptor. The stimulation of stably expressing 293
cells with 5 M PMA at 37°C for 30 and 60 min resulted in
apparent receptor internalization of CXCR4-EGFP, but
PMA treatment at the same concentration did not affect
APJ-EGFP localization on the cell surface, as illustrated in
Fig. 7a. Thus, APJ is similar to CCR5 and not CXCR4 in
this respect.
We also examined the potential of different HIV-1 en-
velope protein gp120s toward inducing APJ internalization.
We treated the 293 cells, which stably express APJ-EGFP,
with recombinant gp120s from the dual-tropic isolates 89.6
and SF2, T-tropic isolate MN, and M-tropic isolate Bal, but
as indicated in Fig. 7b, none of these viral isolates’ enve-
lopes induced APJ internalization, as compared to the
strong internalization of APJ induced by treatment with
Apelin-36 (3 M).
Role of APJ internalization in ligand blocking of HIV-1
infection
As demonstrated above (Fig. 2), the ability of Apelin-13
to induce receptor internalization showed no difference as
compared to Apelin-36. To determine the activity of Ape-
lin-13 and Apelin-36 in blocking HIV-1 entry, we first used
a gene reporter fusion assay to examine the ability of both
peptides toward inhibition of cell–cell fusion, involved with
the APJ receptor and HIV-189.6 gp120. Before initiation of
fusion, the target cells were incubated in the presence or
absence of the test Apelin at 37°C for 30 min, resulting in
sufficient APJ receptor molecules on the cell surface for
internalization. Nonetheless, the fusion data showed that
treatment with Apelin-36 led to blocking of cell–cell fusion
in a dose-dependent manner, whereas addition of Apelin-13
resulted in no inhibitory activity (Fig. 8a), suggesting that
receptor internalization may not associate with ligand inhi-
bition of HIV-1 entry, at least for APJ as a coreceptor.
Since Apelin-36 was demonstrated to induce APJ inter-
nalization and prevent recycling to the cell surface, and to
further confirm the role of receptor internalization in inhi-
bition of HIV-1 entry, we transfected 293-CD4 cells with
APJ and APJ329 for cell fusion assays to study the effects
of Apelin-36 on inhibition of cell membrane fusion. As
shown in Fig. 8b, cell membrane fusion was inhibited by
addition of Apelin-36 in a concentration-dependent manner
for both wild-type APJ and the C-terminally truncated APJ,
and fusion inhibition by Apelin-36 was somewhat, but not
significantly, more efficient in wild-type APJ transfected
cells, as compared to APJ329-transfected cells.
Discussion
The APJ receptor is widely expressed in the human CNS
(Choe et al., 2000; Edinger et al., 1998; Matsumoto et al.,
1996; O’Dowd et al., 1993). APJ and its natural ligand,
Apelin, may play an important role in the hypothalamic
regulation of water intake in the endocrine axis (Lee et al.,
2000; Reaux et al., 2001; Taheri et al., 2002), and in low-
ering blood pressure via a nitric oxide-dependent mecha-
nism (Lee et al., 2000; Tatemoto et al., 2001). Recently the
APJ receptor has been identified as a coreceptor for HIV-1
and SIV for supporting env-mediated membrane fusion or
viral entry in vitro and possibly in vivo (Choe et al., 1998;
Edinger et al., 1998; Puffer et al., 2000; Singh et al., 1999;
Zhang et al., 1998). In this study, our aim was the molecular
characterization of internalization of APJ receptor in trans-
fected cells with APJ C-terminally fused with EGFP, and in
human astrocytes, CNS MVECs and cultured human neu-
rons with a fluorescent peptide ligand. We also evaluated
the role of APJ internalization in ligand inhibition of virus
entry.
The green fluorescent protein (GFP) has been widely
Fig. 5. Effect of the C-terminal truncation of APJ on receptor internalization. 293 cells stably expressing APJ329-EGFP were treated with Apelin-36 (3 M)
at 37°C for 40 min. Cells were then analyzed for APJ329-EGFP internalization via fluorescence microscopy. The data shown are representative of at least
three independent experiments.
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used to construct chimeric proteins to study their localiza-
tion, distribution, and function in different systems. Previ-
ous studies have demonstrated that fusing GPCR with GFP
at the C-terminus led to a fully functional CCKAR (Tara-
sova et al., 1997), 2-Adrenergic receptor (Barak et al.,
1997), and CXCR4 (Tarasova et al., 1998). For this study,
we constructed a chimeric APJ C-terminally fused with
EGFP and established stably expressing cell lines. Com-
pared to the wild-type APJ receptor, APJ-EGFP was found
to have normal signaling and HIV-1 gp120-induced cell
membrane fusion. The expression of APJ-EGFP allows us
to easily detect the receptor moiety under fluorescence mi-
croscopy, for further characterizing receptor internalization
and recycling.
In response to Apelins, the cell-surface APJ-EGFP was
rapidly internalized in a dose-dependent manner. To further
investigate the fate of internalized APJ, the cells expressing
APJ-EGFP were costaining with tetramethylrhodamine-
transferrin or LysoTracker Red. We found that the internal-
ized APJ molecules were colocalized with transferrin, a
marker for early endosomes (Ghosh and Maxfield, 1995),
suggesting that the internalization of APJ induced by Ape-
lins is likely to be via clathrin-coated pits. Previous studies
have shown that the internalized cholecystokinin receptors
(Tarasova et al., 1997) and CCR5 (Ghosh and Maxfield,
1995) accumulate in early endosomes and recycle with
almost 100% efficiency to the cell surface. CXCR4 has been
found to target to lysosomes after SDF-1-induced internal-
ization and to be poorly recycled to the cell surface (Signo-
ret et al., 2000; Tarasova et al., 1998). Here we found that
although Apelin-13 and Apelin-36 have the same potential
in inducing receptor internalization, internalized APJ mol-
Fig. 6. Internalization of the fluorescent Apelin-13 in human primary CNS cells and cultured neurons. The human astrocytes, MVECs, and human cultured
neurons were treated with 5 mM 5-CF-Apelin-13 at 37°C for 60 min. The cells were then analyzed by fluorescence microscopy. The data shown are
representative of at least three independent experiments.
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Fig. 7. Effect of phorbol ester and HIV-1 gp120 on APJ internalization. The stably expressing CXCR4-EGFP and APJ-EGFP 293 cells were incubated with
5 M PMA (a), and APJ-EGFP 293 cells were induced with 50 g/ml HIV-1 gp120s or Apelin-36 (3 M) (b), at 37°C for 60 min. The data shown are
representative of at least three independent experiments.
ecules by treatment with Apelin-13 were recycled to the cell
surface within 60 min, while APJ receptors internalized by
Apelin-36 still remained in the cytoplasm even after a 60
min incubation. It has been found that the range of recycling
times for other GPCRs is between 20 to 60 min (Ashworth
et al., 1995; Marchese and Benovic, 2001; Tarasova et al.,
1997). In our recycling experiments, we incubated the cells
at 37°C for 120 min after removal of Apelin-36, but most
internalized receptors still remained in the cytoplasm.
Mack et al. (1998) have demonstrated that aminooxy-
pentane-RANTES (AOP-RANTES) efficiently induces in-
ternalization of CCR5 and, unlike wild-type RANTES, pre-
vented recovery of CCR5 to the cell surface. The
mechanism through which Apelin-36 and AOP-RANTES
prevented recycling of internalized receptors to the cell
surface remains unclear. It has been established that recy-
cling of internalized receptors needs to be proceeded by
receptor dephosphorylation (Grady et al., 1995 Krueger et
al., 1997). Signoret et al. (2000) found that sustained bind-
ing of AOP-RANTES prevents CCR5 recycling. The recep-
tor-bound Apelin-36 was demonstrated to be barely disso-
ciated from the APJ receptor (Hosoya et al., 2000). It is
possible that the bound Apelin-36 may block dephosphor-
ylation of the internalized APJ and recycling to the cell
surface.
It has been shown previously that serine and threonine
residues in the C-terminal domain of GPCRs are critical for
ligand-induced internalization (Benya et al., 1993; Innamo-
rati et al., 1999; Maestes et al., 1999; Pizard et al., 1999;
Roth et al., 1997). C-terminally truncated CXCR4, CCKBR,
and IL-8 receptor B were found to be expressed and func-
tion as wild-type, but the ligand-induced internalization was
severely impaired (Amara et al., 1997; Lamey et al., 2002;
Maestes et al., 1999; Signoret et al., 1997). To examine the
function of the APJ C-terminus in receptor internalization,
we constructed and APJ mutant with deletion of the C-
terminus and created a stably expressing cell line. We found
that the mutant APJ in stable cells appeared the same as
wild-type by expression levels and coreceptor activity, but
the signaling in response to stimulation with Apelins was
severely impaired, and ligand-induced internalization was
totally blocked. These results are in agreement with previ-
ous studies with CCR5 (Alkhatib et al., 1997; Prado et al.,
1996). However, further studies will be needed to identify
the determinants in the C-terminal domain of APJ involved
in ligand-induced internalization.
CD4 and CXCR4, but not CCR5, have been found to
undergo rapid internalization upon phorbol ester stimulation
(Amara et al., 1997; Kraft et al., 2001, Orsini et al., 1999;
Pelchen-Matthews et al., 1993; Signoret et al., 1997, 1998).
Fig. 8. Apelin-dependent inhibition of cell membrane fusion with the HIV-1 89.6 dual-tropic isolate. (a) Activity of Apelin-36 and Apelin-13 in blocking
APJ-associated cell–cell fusion. (b) Effect of Apelin-36 on inhibition of cell-membrane fusion in cells stably expressing wild-type and C-terminally truncated
APJ. Target cells were cotransfected with plasmids encoding wild-type APJ or the mutant APJ329, CD4, and luciferase under the control of the T7 promoter.
293 effector cells were infected with a vaccinia virus encoding T7 polymerase, and a vaccinia virus encoding the HIV-1 envelope glycoprotein (strain, 89.6).
Before fusion, the target cells were incubated in the presence or absence of the test Apelin for 30 min. Cell mixtures were maintained at 37°C for 4 to 6 h.
Fusion was determined by a luciferase assay. Values are expressed as percentages of luciferase activity. All experiments were repeated at least three times,
and results are expressed as the mean value  SE.
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For the APJ receptor, treatment with PMA had no effect on
receptor internalization. Shin et al. demonstrated that the
motif SQIKRLL in the C-terminal domain of CD4 was
involved in phorbol ester-induced internalization (Hoxie et
al., 1998). A similar motif, SSLKIL, in CXCR4 was found
to be responsible for internalization induced by PMA (Si-
gnoret et al., 1998). Of note, APJ and CCR5 do not have
such a motif in the C-terminal domain. As such, this may be
the reason that APJ and CCR5 are not internalized by
phorbol ester treatment.
Recently, it has been reported that APJ functions as a
coreceptor for the primary T cell tropic isolates HIV-1 (ELI)
and HIV-1 (UG21), the dual-tropic strain HIV-1 (89.6), and
to a lesser extent with the T cell line adapted isolates HIV-1
(MN) and HIV-1 (HXB2), and SIV (mac-316) (Choe et al.,
1998; Edinger et al., 1998; Puffer et al., 2000; Singh et al.,
1999; Zhang et al., 1998). The viral envelope glycoprotein,
gp120, has been reported to bind to CXCR4 and to induce
rapid internalization of cell-surface CXCR4, both in the
presence and in the absence of CD4 (Tarasova et al., 1998).
Our results showed that the viral envelope proteins were
unable to induce internalization and signaling of the APJ
receptor, although these viruses use APJ as a coreceptor to
infect human cells, suggesting that the viral envelope gp120
binds to APJ at different sites from Apelin ligands.
The APJ receptor is expressed in human neurons, oligo-
dendrocytes, and astrocytes (Choe et al., 2000). Thus, it is
important to examine the internalization of APJ receptor in
primary human CNS cells and neurons in culture. In this
study, a fluorescent peptide Apelin was developed to di-
rectly probe APJ internalization in primary human brain
MVECs, astrocytes, and cultured human neurons (i.e., fully
differentiated NT2 cells). Although 5-CF-Apelin-13 bound
to APJ with lower affinity than Apelin-13, the green fluo-
rescence was distributed in the cytoplasm upon incubation
with 5-CF-Apelin-13. Previous studies have demonstrated
that Apelin-36 binds to APJ with higher affinity than Ape-
lin-13 (Shin et al., 1990), but Apelin-13 is found to be more
active in suppression of cAMP production, promotion of
acidification rates, and chemotaxis for CHO-A10 cells, as
compared to Apelin-36 (Habata et al., 1999; Hosoya et al.,
2000; Shin et al., 1990), indicating that for APJ, binding
affinity is not critical for Apelin-induced receptor function.
When the fluorescent peptides were applied to primary
human CNS cells and cultured neurons, differences of dis-
tribution of fluorescent peptides in the cytoplasm was ob-
served among MVECs, astrocytes, and neurons. Neurons
were robustly and completely stained by green fluorescence,
while astrocytes were less strongly labeled with 5-CF-Ape-
lin-13. In MVECs, very weak distribution of fluorescent
peptides in the cytoplasm was observed. These initial results
were consistent with observations of APJ expression in
these cells. However, this fluorescent peptide provides us
with an excellent tool to further investigate APJ internal-
ization and recycling in primary human CNS cells and
cultured neurons.
CXCR4 and CCR5 are the two main coreceptors for the
entry of HIV-1 into human cells (Deng et al., 1996;
Kawamata et al., 2001). The natural ligands for CXCR4:
SDF-1, and for CCR5: RANTES, MIP-1, and MIP-1,
inhibit the entry of certain HIV-1 strains into cells (Bleul et
al., 1996; Choe et al., 1996; Kawamata et al., 2001). Al-
though initial studies suggest that the observed HIV-1 sup-
pressive effects of chemokine antagonists are due to com-
petitive inhibition of gp120 binding to the coreceptors
(Arenzana-Seisdedos et al., 1996; Cocchi et al., 1995), re-
cent studies with CXCR4 and CCR5 have demonstrated that
coreceptor internalization contributes to chemokine inhibi-
tion of virus entry (Amara et al., 1997; Prado et al., 1996;
Signoret et al., 1997). Apelins have been found to be able to
block the activity of APJ as an HIV-1 coreceptor (Cayabyab
et al., 2000; Puffer et al., 2000; Zou et al., 2000). However,
the mechanism by which Apelins block APJ-dependent cell-
membrane fusion and virus entry is still unclear. In the
present study, we found that Apelin-36 inhibited cell-mem-
brane fusion, involved with APJ and the 89.6 isolate gp120,
more efficiently than Apelin-13. We do not know whether
the higher efficiency in inhibition of cell–cell fusion with
Apelin-36 is due to higher binding affinity (Shin et al.,
1990), or to the prevention of recycling of internalized
receptors. To further evaluate the role of receptor internal-
ization in inhibition of HIV-1 entry, we compared the effi-
cacy of Apelin-36 in blocking cell fusion in wild-type and
C-terminally truncated APJ. We found that although Ape-
lin-36 inhibited cell-membrane fusion in both wild-type and
truncated APJ-expressing cells, the activity of Apelin-36 in
blocking cell membrane fusion was slightly more efficient
in APJ-transfected cells than in cells expressing C-termi-
nally truncated APJ. These results suggested that inhibitory
activity of Apelin-36 in cell membrane HIV-1 fusion was
mainly due to steric interference, and receptor internaliza-
tion only slightly contributed to efficient ligand blocking of
virus entry.
In summary, this is the first report to use fusion con-
structs of the APJ receptor with EGFP at the C-terminus and
fluorescent peptide Apelin-13 to characterize the ligand-
induced internalization of APJ in transfected cells and in
primary human CNS cell types. We found that a rapid
internalization of APJ receptor was induced by stimulation
with Apelin-36 and Apelin-13, in a dose-dependent manner.
The internalized APJ was colocalized with transferrin re-
ceptors. Interestingly, we demonstrated that the internalized
APJ were recycled to the cell surface within 60 min after
removal of Apelin-13, but most of the internalized APJ still
remained in the cytoplasm even 2 h after washout of Apelin-
36. Neurons were completely stained by fluorescent pep-
tides, and astrocytes were less intensely labeled with 5-CF-
Apelin-13, while in MVECs, only very weak distribution of
green fluorescence in the cytoplasm was observed. Ape-
lin-36 blocked cell membrane fusion with gp120 mainly due
to steric interference. Further studies in model blood:brain
barrier (BBB) systems with primary human CNS cell types
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expressing APJ will be necessary to extend these initial
analyses (Mukhtar and Pomerantz, 2000). Tissue levels of
the Apelins throughout the CNS in vivo should now be
more broadly studied to determine if they may have some
inhibitory effects on HIV-1 infections.
Understanding the relatively enigmatic APJ chemokine
coreceptor will assist in dissecting the molecular parameters
of HIV-1 neuropathogenesis. These data, and studies on
other key chemokine coreceptors (Zhou et al., 2001), are
necessary in the rational design of molecular and pharma-
cological therapeutics to combat HIV-1 infection in the
CNS and lentiviral neuroinvasion.
Materials and Methods
Materials
Dulbecco’s modified Eagle’s medium (DMEM), fetal
bovine serum, and G418 were purchased from Life Tech-
nologies, Inc. Rhodamine red concanavalin A (ConA), tet-
ramethylrhodamine-transferrin, LysoTracker Red, furo-2,
and Pluronic F-127 were purchased from Molecular Probes
Inc. (Eugene, OR). The plasmid, pCDNA-APJ, recombinant
89.6 gp120, recombinant vaccinia viruses encoding an en-
velope glycoprotein of HIV-1 vBD3 (89.6), and vTF1.1
encoding T7 RNA polymerase were generous gifts from Dr.
Robert W. Doms, University of Pennsylvania. The vector,
pEGFP-N1, was purchased from Clontech Laboratories,
Inc. (Palo Alto, CA). Anti-human APJ monoclonal antibody
MAB856 was purchased from R&D Systems, Inc. (Minne-
apolis, MN). The following reagents were obtained from the
AIDS Research and Reference Reagent Program (Division
of AIDS, NIAID, NIH): recombinant MN gp120, Bal
gp120, and SF2 gp120.
Cells and cell culture
The human CNS microvascular endothelial cells
(MVECs) were obtained from Cell System Corp., Kirkland,
WA and grown at 37°C, 5% CO2, 100% humidity in human
endothelial growth medium. The human fetal astrocytes
were purchased from Advanced Bioscience Resources, Inc.
(Alameda, CA) and maintained in growth medium includ-
ing Ham’s F12/DMEM with high-glucose fetal calf serum,
1 M HEPES, 7.5% sodium bicarbonate, penicillin-strepto-
mycin(1), and glutamine. The Ntera2/D1 (NT2) cell line,
which is derived from a human teratocarcinoma (Lee and
Andrews, 1986), was obtained from the American Tissue
Culture Collection (Rockville, MD). The NT2 cells were
maintained and differentiated into fully mature human neu-
rons, as described previously (Mukhtar and Pomerantz,
2000). The CHO cell line was obtained from the American
Type Culture Collection. The 293 cell line was obtained
from the AIDS Research and Reference Reagent Program
(Division of AIDS, NIAID, NIH). 293 and CHO cells were
maintained in DMEM plus 10% fetal bovine serum.
DNA constructions
A C-terminally truncated APJ (APJ329) was constructed
by altering codon-330 into a stop codon and mutating
serine-319 and serine-312 into alanines by PCR (313-
DPRFRQACTSMICCGQSRCAGTSHSSSGEKSASYSS-
GHSGPGPNMGKGGEQMHEKSIPYSQETLVVD-CO-
OH; 329-DPRFRQACTAMLCCGQA-COOH). The full open
reading frames (ORF) of wild-type and C-terminally trun-
cated APJ and CXCR4 were amplified using PCR and
subcloned in-frame into HindIII and BamHI sites of
pEGFP-N1 vector. All constructs were sequenced to con-
firm the correct sequences and orientations. The plasmid
constructs of wild-type and C-terminus-truncated APJ were
transfected into 293 cells by the calcium-phosphate precip-
itation method. Twenty-four hours after transfection, selec-
tion for stably expressing cells was initiated by the addition
of G418 (800 g/ml). Transfected cells were evaluated for
expression levels of APJ at the cell surface by flow cytom-
etry.
Flow cytometry
Stable APJ transfected 293 cells (2  105) were washed
with fluorescence-activated cell sorting (FACS) buffer
(0.3% bovine serum albumin, 0.05% sodium azide in PBS)
and incubated with an anti-APJ monoclonal antibody (mAb)
MAB856 (10 g/ml) for 30 min at 4°C. After washing with
FACS buffer, cells were incubated with 10 g fluorescein
isothiocyanate (FITC)-conjugated goat anti-mouse IgG
(Sigma) for 30 min at 4°C. After washing twice with FACS
buffer, cells were fixed in a buffer (2% paraformaldehyde in
PBS) and then analyzed on a FACScan flow cytometer
(Coulter EPICS Elite, Coolten Corp., Hialeah, FL). For
detection of APJ internalization, cells were first incubated
with Apelin-13 or Apelin-36 at 37°C for 40 min and then
washed with FACS buffer. After staining, cells were ana-
lyzed by FACS.
Fluorescence microscopy
The stable APJ or C-terminus-truncated APJ expressing
293 cells were seeded on two-chamber slides (Nunc, Inc.)
and incubated at 37°C overnight. After treatment with Ape-
lins or phorbol myristate acetate (PMA), cells were washed
in PBS and then fixed in PBS containing 2% paraformal-
dehyde for 10 min. Fluorescence microscopy was per-
formed on an Olympus System microscope, model BX60,
with fluorescence attachment BX-FLA. For time-course
studies of APJ-EGFP internalization, the cells were treated
with 2 M Apelin-13 or Apelin-36 in the presence of 25
g/ml cycloheximide at 37°C for 30 min. After washing
with medium, the cells were incubated at 37°C for various
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time periods and observed with fluorescence microscopy.
For colocalization of APJ-GFP with tetramethylrhodamine-
transferrin or LysoTracker Red, the cells were treated with
1 M tetramethylrhodamine-transferrin or 50 nM Lyso-
Tracker Red at 37°C for 15 min, rinsed with medium, and
incubated with 2 M Apelin-13 or Apelin-36 for different
time periods. The cells were finally rinsed with PBS and
fixed with 2% paraformaldehyde and then analyzed with
fluorescence microscopy.
Intracellular calcium measurements
Utilizing a modified procedure published by others
(Donnadieur et al., 1994; Heveker et al., 1998), untrans-
duced 293 cells and APJ or C-terminus-truncated APJ sta-
bly transfected 293 cells were cultured in DMEM contain-
ing 10% FBS. Cells were trypsinized and washed twice with
PBS. For Ca2 mobilization studies, 5  106 cells/ml were
loaded with the fluorescent dye, fura-2 (3 M), and 0.05%
F172 in Hanks balanced salt solution (140 mM NaCl, 5 mM
KCl, 10 mM HEPES pH 7.4, 1 mM CaCl2, 1 mM MgCl2, 1
mg/ml glucose, and 0.025% BSA), for 30 min at 37°C. The
cells were washed three times and resuspended at a concen-
tration of 30 to 40  106/ml; then 1.5 to 2  106 cells were
tested in the same buffer. Intracellular Ca2 mobilization
was measured using excitation at 340 and 380 nm on a
fluorescence spectrometer (Perkin–Elmer LS50B, Bea-
consfield, U.K.), upon stimulation with Apelins. Intracellu-
lar Ca2 concentrations were calculated using a fluores-
cence spectrometer measurement program.
Gene reporter fusion assay
A gene reporter fusion assay was used to determine the
coreceptor activity of APJ in mediating HIV-1 entry, fol-
lowing a modified procedure published by others (Nuss-
baum et al., 1994; Rucker et al., 1997). Briefly, the effector
293 cells were infected with recombinant vaccinia virus
with HIV-1 Env protein (strain 89.6) and T7 RNA poly-
merase for 2 h. Infected cells were then trypsinized, washed
with PBS, resuspended in medium, and incubated overnight
at 32°C in the presence of rifampicin (100 g/ml). Target
cells were cotransfected in six-well plates with plasmids
encoding CD4, wild-type APJ, and luciferase under the
control of the T7 promoter, using the calcium-phosphate
precipitation method. Four hours after transfection, cells
were detached, seeded in 24-well plates, and incubated at
37°C overnight. Before fusion, the target cells were incu-
bated in the presence or absence of the test Apelin for 30
min. To initiate fusion, 105 effector cells were added to each
well and incubated at 37°C in the presence or absence of the
test Apelin. After 5 h, cells were lysed in 150 l of reporter
lysis buffer (Pharmingen) and assayed for luciferase activity
by using commercially available reagents (Pharmingen) in a
luminometer.
Peptide synthesis
The peptides Apelin-13 and Apelin-36 were prepared by
solid-phase synthesis using Fmoc-strategy on a 430A pep-
tide synthesizer (Applied Biosystems, Foster City, CA) and
a 9050 Pepsynthesizer Plus (Perseptive Biosystems, Cam-
bridge, MA). Crude peptides were purified by preparative
reverse-phase high-performance liquid chromatography us-
ing a Dynamax-300Å C18 25 cm  21.4 mm i.d. column
with a flow rate of 9 ml/min and two solvent systems of
0.1% TFA/H2O and 0.1% TFA/acetonitrile. Fractions con-
taining the appropriate peptide were pooled together and
lyophilized. The purity of the final product was assessed by
analytical reverse-phase high-performance liquid chroma-
tography, capillary electrophoresis, and matrix-assisted la-
ser desorption/ionization time-of-flight mass spectrometry.
Conjugation of 5-carboxyfluorescein to Apelin-13
Apelin-13, in which the side chain of Lys was protected
with (4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl
(dde), was treated with 2% hydrazine in DMF, allowing the
selective deprotection of dde group from the side chain Lys.
Since hydrazine will remove Fmoc, the N-terminus of the
peptide Apelin-13 was protected with Boc. Then, the pep-
tide resin was treated with 5-carboxyfluorescein (2.5 equiv),
HBTU (2.5 equiv), HOBT (2.5 equiv), and DIPEA (5 equiv)
in DMF (minimum to cover the resin) at room temperature
overnight. The coupling was repeated to obtain a negative
Kaiser test, if necessary. Final deprotection of all other side
chain protecting groups, cleavage from the resin, purifica-
tion by reversed-phase HPLC, and analytical characteriza-
tion were carried out, as described above for the correspond-
ing peptide.
Acknowledgments
The authors thank Ms. Rita M. Victor and Ms. Brenda O.
Gordon for excellent secretarial assistance, and Dr. Robert
W. Doms for providing APJ cDNA, recombinant 89.6
gp120, and vaccinia viruses. A number of reagents, as listed
under Materials and Methods, were obtained from the AIDS
Research and Reference Reagent Program, Division of
AIDS, NIAID, NIH. This work was supported in part by
USPHS Grants NS27405, MH58526, and NS41864 to
R.J.P.
References
Albright, A., Shieh, J., Itoh, T., Lee, B., Pleasure, D., O’Connor, M., Doms,
R., Gonzalez-Scarano, F., 1999. Microglia express CCR5, CXCR4, and
CCR3, but of these, CCR5 is the principal coreceptor for human
immunodeficiency virus type 1 dementia isolates. J. Virol. 73 (1),
205–213.
34 N. Zhou et al. / Virology 307 (2003) 22–36
Alkhatib, G., Locati, M., Kennedy, P., Murphy, P., Berger, E., 1997. HIV-1
coreceptor activity of CCR5 and its inhibition by chemokines: inde-
pendence from G protein signaling and importance of coreceptor down-
modulation. Virology 234 (2), 340–348.
Amara, A., Gall, S.L., Schwartz, O., Salamero, J., Montes, M., Loetscher,
P., Baggiolini, M., Virelizier, J.-L., Arenzana-Seisdedos, F., 1997. HIV
coreceptor downregulation as antiviral principle: SDF-1-dependent
internalization of the chemokine receptor CXCR4 contributes to inhi-
bition of HIV replication. J. Exp. Med. 186 (1), 139–146.
Aramor, I., Ferguson, S., Bieniasz, P., Zhang, J., Cullen, B., Cullen, M.,
1997. Molecular mechanism of desensitization of the chemokine re-
ceptor CCR-5: receptor signaling and internalization are dissociable
from its role as an HIV-1 co-receptor. EMBO J. 16 (15), 4606–4616.
Arenzana-Seisdedos, F., Virelizier, J.L., Rousset, D., Clark-Lewis, I.,
Loetscher, P., Moser, B., Baggiolini, M., 1996. HIV blocked by che-
mokine antagonist. Nature 383 (6599), 400.
Ashworth, R., Yu, R., Nelson, E., Dermer, S., Gershengorn, M., Hinkle, P.,
1995. Visualization of the thyrotropin-releasing hormone receptor and
its ligand during endocytosis and recycling. Proc. Natl. Acad. Sci. USA
92 (2), 512–516.
Barak, L., Ferguson, S., Zhang, J., Martenson, C., Meyer, T., Caron, M.,
1997. Internal trafficking and surface mobility of a functionally intact
beta 2-adrenergic receptor-green fluorescent protein conjugate. Mol.
Pharmacol. 51 (2), 177–184.
Benya, R., Fathi, Z., Battey, J., Jensen, R., 1993. Serines and threonines in
the gastrin-releasing peptide receptor carboxyl terminus mediate inter-
nalization. J. Biol. Chem. 268 (27), 20285–20290.
Bleul, C.C., Farzan, M., Choe, H., Parolin, C., Clark-Lewis, I., Sodroski, J.,
1996. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/
fusin and blocks HIV-1 entry. Nature 382 (6594), 829–833.
Cayabyab, M., Hinuma, S., Farzan, M., Choe, H., Fukusumi, S., Kitada, C.,
Nishizawa, N., Hosoya, M., Nishimura, O., Messele, T., Pollakis, G.,
Goudsmit, J., Fujino, M., Sodroski, J., 2000. Apelin, the natural ligand
of the orphan seven-transmembrane receptor APJ, inhibits human im-
munodeficiency virus type 1 entry. J. Virol. 74 (24), 11972–11976.
Choe, H., Farzan, M., Konkel, M., Martin, K., Sun, Y., Marcon, L.,
Cayabyab, M., Berman, M., Dorf, M., Gerard, N., Gerard, C., Sodroski,
J., 1998. The orphan seven-transmembrane receptor APJ supports the
entry of primary T-cell-line-tropic and dualtropic human immunodefi-
ciency virus type 1. J. Virol. 72 (7), 6113–6118.
Choe, H., Farzan, M., Sun, Y., Sullivan, N., Rollins, B., Ponath, P.D., Wu,
L., Mackay, C.R., LaRosa, G., Newman, W., Gerard, N., Gerard, C.,
Sodroski, J.S., 1996. The beta-chemokine receptors CCR3 and CCR5
facilitate infection by primary HIV-1 isolates. Cell 85 (7), 1135–1148.
Choe, W., Albright, A., Sulcove, J., Jaffer, S., Hesselgesser, J., Lavi, E.,
Crino, P., Kolson, D., 2000. Functional expression of the seven-trans-
membrane HIV-1 co-receptor APJ in neural cells. J. Neurovirol. 6
(Suppl. 1), S61–S69.
Cocchi, F., DeVico, A.L., Garzino-Demo, A., Arya, S.K., Gallo, R.C.,
Lusso, P., 1995. Identification of RANTES, MIP-1 alpha, and MIP-1
beta as the major HIV-suppressive factors produced by CD8 T cells.
Science 270 (5243), 1811–1815.
Deng, H., Rong, L., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M.,
Marzio, P.D., Marmon, S., Sutton, R.E., Hill, C.M., Davis, C.B.,
Peiper, S.C., Schall, T.J., Littman, D.R., Landau, N.R., 1996. Identifi-
cation of a major co-receptor for primary isolates of HIV-1. Nature
381, 661–666.
Donnadieu, E., Bismuth, G., Trautmann, A., 1994. Antigen recognition by
helper T cells elicits a sequence of distinct changes of their shape and
intracellular calcium. Curr. Biol. 4 (7), 584–595.
Doranz, B., Orsini, M., Turner, J., Hoffman, T., Berson, J., Hoxie, J.,
Peiper, S., Brass, L., Doms, R., 1999. Identification of CXCR4 domains
that support coreceptor and chemokine receptor functions. J. Virol. 73
(4), 2752–2761.
Doranz, B.J., Rucker, J., Yi, Y., Smyth, R.J., Samson, M., Peiper, S.C.,
Parmentier, M., Collman, R.G., Doms, R.W., 1996. A dual-tropic
primary HIV-1 isolate that uses fusin and the beta-chemokine receptors
CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85 (7), 1149–
1158.
Dragic, T., Litwin, V., Allaway, G.P., Martin, S.R., Huang, Y., Nagashima,
K.A., Cayanan, C., Maddon, P.J., Koup, R.A., Moore, J.P., Paxton,
W.A., 1996. HIV-1 entry into CD4 cells is mediated by the chemo-
kine receptor CC-CKR-5. Nature 381, 667–673.
Edinger, A., Hoffman, T., Sharron, M., Lee, B., Yi, Y., Choe, W., Kolson,
D., Mitrovic, B., Zhou, Y., Faulds, D., Collman, R., Hesselgesser, J.,
Horuk, R., Doms, R., 1998. An orphan seven-transmembrane domain
receptor expressed widely in the brain functions as a coreceptor for
human immunodeficiency virus type 1 and simian immunodeficiency
virus. J. Virol. 72 (10), 7934–7940.
Feng, Y., Broder, C.C., Kennedy, P.E., Berger, E.A., 1996. HIV-1 entry
cofactor: functional cDNA cloning of a seven-transmembrane, G pro-
tein-coupled receptor. Science 272 (5263), 872–877.
Ghosh, R.N., Maxfield, F.R., 1995. Evidence for nonvectorial, retrograde
transferrin trafficking in the early endosomes of HEp2 cells. J. Cell
Biol. 128, 549–561.
Grady, E., Slice, L., Brant, W., Walsh, J., Payan, D., Bunnett, N., 1995.
Direct observation of endocytosis of gastrin releasing peptide and its
receptor. J. Biol. Chem. 270 (9), 4603–4611.
Habata, Y., Fujii, R., Hosoya, M., Fukusumi, S., Kawamata, Y., Hinuma,
S., Kitada, C., Nishizawa, N., Murosaki, S., Kurokawa, T., Onda, H.,
Tatemoto, K., Fujino, M., 1999. Apelin, the natural ligand of the
orphan receptor APJ, is abundantly secreted in the colostrum. Biochim.
Biophys. Acta 1452 (1), 25–35.
Heveker, N., Montes, M., Germeroth, L., Amara, A., Trautmann, A.,
Alizon, M., Schneider-Mergener, J., 1998. Dissociation of the signal-
ling and antiviral properties of SDF-1-derived small peptides. Curr.
Biol. 8 (7), 369–376.
Hosoya, M., Kawamata, Y., Fukusumi, S., Fujii, R., Habata, Y., Hinuma,
S., Kitada, C., Honda, S., Kurokawa, T., Onda, H., Nishimura, O.,
Fujino, M., 2000. Molecular and functional characteristics of APJ.
Tissue distribution of mRNA and interaction with the endogenous
ligand apelin. J. Biol. Chem. 275 (28), 21061–21067.
Hoxie, J., Rackowski, J., Haggarty, B., Gaulton, G., 1988. T4 endocytosis
and phosphorylation induced by phorbol esters but not by mitogen or
HIV infection. J. Immunol. 140 (3), 786–795.
Innamorati, G., Sadeghi, H., Birnbaumer, M., 1999. Phosphorylation and
recycling kinetics of G protein-coupled receptors. J. Recept. Signal
Transduct. Res. 19 (1–4), 1315–1326.
Kawamata, Y., Habata, Y., Fukusumi, S., Hosoya, M., Fujii, R., Hinuma,
S., Nishizawa, N., Kitada, C., Onda, H., Nishimura, O., Fujino, M.,
2001. Molecular properties of apelin: tissue distribution and receptor
binding. Biochim. Biophys. Acta 1538 (2–3), 162–171.
Kraft, K., Olbrich, H., Majoul, I., Mack, M., Proudfoot, A., Oppermann,
M., 2001. Characterization of sequence determinants within the car-
boxyl-terminal domain of chemokine receptor CCR5 that regulate
signaling and receptor internalization. J. Biol. Chem. 276 (37), 34408–
34418.
Krueger, K.M., Daaka, Y., Pitcher, J.A., Lefko, R.J., 1997. The role of
sequestration in G protein-coupled receptor resensitization regulaton of
2-adrenergic receptor dephosphorylation by vesicular acidification.
J. Biol. Chem. 272 (1), 5–8.
Lamey, M., Thompson, M., Varghese, G., Chi, H., Sawzdargo, M., George,
S.R., O’Dowd, B.F., 2002. Distinct residues in the carboxyl tail medi-
ate agonist-induced desensitization and internalization of the human
dopamine D1 receptor. J. Biol. Chem. 277 (11), 9415–9421.
Lee, D., Cheng, R., Nguyen, T., Fan, T., Kariyawasam, A., Liu, Y.,
Osmond, D., George, S., O’Dowd, B., 2000. Characterization of apelin,
the ligand for the APJ receptor. J. Neurochem. 74 (1), 34–41.
Lee, V., Andrews, P., 1986. Differentiation of NTERA-2 clonal human
embryonal carcinoma cells into neurons involves the induction of all
three neurofilament proteins. J. Neurosci. 6 (2), 514–521.
Mack, M., Luckow, B., Nelson, P.J., Cihak, J., Simmons, G., Clapham,
P.R., Signoret, N., Marsh, M., Stangassinger, M., Borlat, F., Wells,
T.N.C., Schlo¨ndorff, D., Proudfoot, A.E.I., 1998. Aminooxypentane-
35N. Zhou et al. / Virology 307 (2003) 22–36
RANTES induces CCR5 internalization but inhibits recycling: a novel
inhibitory mechanism of HIV infectivity. J. Exp. Med. 187 (8), 1215–
1224.
Maestes, D.C., Potter, R.M., Prossnitz, E.R., 1999. Differential phosphor-
ylation paradigms dictate desensitization and internalization of the
N-formyl peptide receptor. J. Biol. Chem. 274 (42), 29791–29795.
Marchese, A., Benovic, J., 2001. Agonist-promoted ubiquitination of the G
protein-coupled receptor CXCR4 mediates lysosomal sorting. J. Biol.
Chem. 276 (49), 45509–45512.
Matsumoto, M., Hidaka, K., Akiho, H., Tada, S., Okada, M., Yamaguchi,
T., 1996. Low stringency hybridization study of the dopamine D4
receptor revealed D4-like mRNA distribution of the orphan seven-
transmembrane receptor, APJ, in human brain. Neurosci. Lett. 219 (2),
119–122.
Mukhtar, M., Pomerantz, R., 2000. Development of an in vitro blood-brain
barrier model to study molecular neuropathogenesis and neurovirologic
disorders induced by human immunodeficiency virus type 1 infection.
J. Hum. Virol. 3 (6), 324–334.
Nussbaum, O., Broder, C.C., Berger, E.A., 1994. Fusogenic mechanism of
envelope-virus glycoproteins by a novel recombinant vaccinia virus-
based assay quantitating cell fusion-dependent reporter gene activation.
J. Virol. 68, 5411–5422.
O’Dowd, B.F., Heiber, M., Chan, A., Heng, H.H., Tsui, L.C., Kennedy,
J.L., Shi, X., Petronis, A., George, S.R., Nguyen, T., 1993. A human
gene that shows identity with the gene encoding the angiotensin recep-
tor is located on chromosome 11. Gene 136 (1–2), 355–360.
Orsini, M.J., Parent, J.-L., Mundell, S.J., Benovic, J.L., 1999. Trafficking
of the HIV coreceptor CXCR4. Role of arrestins and identification of
residues in the C-terminal tail tha mediate receptor internalization.
J. Biol. Chem. 274 (43), 31076–31086.
Pelchen-Matthews, A., Parsons, I., Marsh, M., 1993. Phorbol ester-induced
downregulation of CD4 is a multistep process involving dissociation
from p56lck, increased association with clathrin-coated pits, and al-
tered endosomal sorting. J. Exp. Med. 178 (4), 1209–1222.
Pizard, A., Blaukat, A., Mu¨ller-Esterl, W., Alhenc-Gelas, F., Rajerison,
R.M., 1999. Bradykinin-induced internalization of the human B2 re-
ceptor requires phosphorylation of three serine and two threonine
residues at its carboxyl tail. J. Biol. Chem. 274 (18), 12738–12747.
Pohl, M., Silvente-Poirot, S., Pisegna, J.R., Tarasova, N.I., Wank, S.A.,
1997. Importance of the carboxyl terminus for ligand-induced internal-
ization of cholecystokinin receptors. Demonstration of the carboxyl
terminus for ligand-induced internalization of the rat cholecystokinin
type B receptor but not the type A receptor. J. Biol. Chem. 272,
18179–18184.
Prado, G., Suzuki, H., Wilkinson, N., Cousins, B., Navarro, J., 1996. Role
of the C terminus of the interleukin 8 receptor in signal transduction
and internalization. J. Biol. Chem. 271 (32), 19186–19190.
Puffer, B., Sharron, M., Coughlan, C., Baribaud, F., McManus, C., Lee, B.,
David, J., Price, K., Horuk, R., Tsang, M., Doms, R., 2000. Expression
and coreceptor function of APJ for primate immunodeficiency viruses.
Virology 276 (2), 435–444.
Reaux, A., De Mota, N., Skultetyova, I.Z.L., El Messari, S., Gallatz, K.,
Corvol, P., Palkovits, M., Llorens-Cortes, C., 2001. Physiological role
of a novel neuropeptide, apelin, and its receptor in the rat brain.
J. Neurosci. 77 (4), 1085–1096.
Roth, A., Kreienkamp, H.-J., Meyerhof, W., Richter, D., 1997. Phosphor-
ylation of four amino acid residues in the carboxyl terminus of the rat
somatostatin receptor subtype 3 is crucial for its desensitization and
internalization. J. Biol. Chem. 272 (38), 23769–23774.
Rucker, J., Doranz, B., Edinger, A., Long, D., Berson, J., Doms, R., 1997.
Cell-cell fusion assay to study role of chemokine receptors in human
immunodeficiency virus type 1 entry. Methods Enzymol. 288, 118–
133.
Shieh, J., Albright, A., Sharron, M., Gartner, S., Strizki, J., Doms, R.,
Gonzalez-Scarano, F., 1998. Chemokine receptor utilization by human
immunodeficiency virus type 1 isolates that replicate in microglia.
J. Virol. 72 (5), 4243–4249.
Shin, J., Doyle, C., Yang, Z., Kappes, D., Strominger, J., 1990. Structural
features of the cytoplasmic region of CD4 required for internalization.
EMBO J. 9 (2), 425–434.
Signoret, N., Oldridge, J., Pelchen-Matthews, A., Klasse, P.J., Tran, T.,
Brass, L.F., Rosenkilde, M.M., Schwartz, T.W., William Holmes,
W.D., Luther, M.A., Wells, T.N.C., Hoxie, J.A., Marsh, M., 1997.
Phorbol esters and SDF-1 induce rapid endocytosis and down modu-
lation of the chemokine receptor CXCR4. J. Cell Biol. 139 (3), 651–
664.
Signoret, N., Pelchen-Matthews, A., Mack, M., Proudfoot, A., Marsh, M.,
2000. Endocytosis and recycling of the HIV coreceptor CCR5. J. Cell
Biol. 151 (6), 1281–1294.
Signoret, N., Rosenkilde, M., Klasse, P., Schwartz, T., Malim, M., Hoxie,
J., Marsh, M., 1998. Differential regulation of CXCR4 and CCR5
endocytosis. J. Cell. Sci. 111 (Pt 18), 2819–2830.
Simmons, G., Clapham, P.R., Picard, L., Offord, R.E., Rosenkilde, M.M.,
Schwartz, T., Buser, R., Wells, T.N.C., 1997. Potent inhibition of
HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5
antagonist. Science 276 (5310), 276–279.
Singh, A., Besson, G., Mobasher, A., Collman, R., 1999. Patterns of
chemokine receptor fusion cofactor utilization by human immunodefi-
ciency virus type 1 variants from the lungs and blood. J. Virol. 73 (8),
6680–6690.
Stauber, R., Rulong, S., Palm, G., Tarasova, N., 1999. Direct visualization
of HIV-1 entry: mechanisms and role of cell surface receptors. Bio-
chem. Biophys. Res. Commun. 258 (3), 695–702.
Taheri, S., Murphy, K., Cohen, M., Sujkovic, E., Kennedy, A., Dhillo, W.,
Dakin, C., Sajedi, A., Ghatei, M., Bloom, S., 2002. The effects of
centrally administered apelin-13 on food intake, water intake and pi-
tuitary hormone release in rats. Biochem. Biophys. Res. Commun. 291
(5), 1208–1212.
Tarasova, N., Stauber, R., Michejda, C., 1998. Spontaneous and ligand-
induced trafficking of CXC-chemokine receptor 4. J. Biol. Chem. 273
(26), 15883–15886.
Tarasova, N.I., Stauber, R.H., Choi, J.K., Hudson, E.A., Czerwinski, G.,
Miller, J.L., Pavlakis, G.N., Michejda, C.J., Wank, S.A., 1997. Visu-
alization of G protein-coupled receptor trafficking with the aid of the
green fluorescent protein. Endocytosis and recycling of cholecystokinin
receptor type A. J. Biol. Chem. 272 (23), 14817–14824.
Tatemoto, K., Hosoya, M., Habata, Y., Fujii, R., Kakegawa, T., Zou, M.,
Kawamata, Y., Fukusumi, S., Hinuma, S., Kitada, C., Kurokawa, T.,
Onda, H., Fujino, M., 1998. Isolation and characterization of a novel
endogenous peptide ligand for the human APJ receptor. Biochem.
Biophys. Res. Commun. 251 (2), 471–476.
Tatemoto, K., Takayama, K., Zou, M., Kumaki, I., Zhang, W., Kumano,
K., Fujimiya, M., 2001. The novel peptide apelin lowers blood pressure
via a nitric oxide-dependent mechanism. Regul. Pept. 99 (2–3), 87–92.
Zhang, Y., Dragic, T., Cao, Y., Kostrikis, L., Kwon, D., Littman, D.,
KewalRamani, V., Moore, J., 1998. Use of coreceptors other than
CCR5 by non-syncytium-inducing adult and pediatric isolates of hu-
man immunodeficiency virus type 1 is rare in vitro. J. Virol. 72 (11),
9337–9344.
Zhou, N., Luo, Z., Luo, J., Liu, D., Hall, J.W., Pomerantz, R.J., Huang, Z.,
2001. Structural and functional characterization of human CXCR4 as a
chemokine receptor and HIV-1 co-receptor by mutagenesis and mo-
lecular modeling studies. J. Biol. Chem. 276, 42826–52833.
Zimmermann, N., Conkright, J.J., Rothenberg, M.E., 1999. CC Chemokine
receptor-3 undergoes prolonged ligand-induced internalization. J. Biol.
Chem. 274 (18), 12611–12618.
Zou, M., Liu, H., Haraguchi, Y., Soda, Y., Tatemoto, K., Hoshino, H.,
2000. Apelin peptides block the entry of human immunodeficiency
virus (HIV). FEBS Lett. 473 (1), 15–18.
36 N. Zhou et al. / Virology 307 (2003) 22–36
